{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T04:01:54Z","timestamp":1784952114364,"version":"3.55.0"},"reference-count":43,"publisher":"Japanese Society of Internal Medicine","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2026]]},"DOI":"10.2169\/internalmedicine.7329-26","type":"journal-article","created":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T22:10:25Z","timestamp":1784931025000},"source":"Crossref","is-referenced-by-count":0,"title":["Clinical Associations of Successful Weaning from Impella Support in Non-ischemic Cardiogenic Shock"],"prefix":"10.2169","author":[{"given":"Yuichiro","family":"Koyama","sequence":"first","affiliation":[{"name":"Department of Cardiology, Nagoya University Graduate School of Medicine, Japan"},{"name":"Department of Cardiology, Kasugai Municipal Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryota","family":"Morimoto","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Nagoya University Graduate School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shin","family":"Nagai","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Nagoya University Graduate School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asuka","family":"Nozaki","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Nagoya University Graduate School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiaki","family":"Mizuno","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Nagoya University Graduate School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryota","family":"Ito","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Nagoya University Graduate School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiyota","family":"Kondo","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Nagoya University Graduate School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shotaro","family":"Komeyama","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Nagoya University Graduate School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Fujikawa","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Kasugai Municipal Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shingo","family":"Kazama","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Nagoya University Graduate School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Hiraiwa","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Nagoya University Graduate School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toru","family":"Kondo","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Nagoya University Graduate School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toyoaki","family":"Murohara","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Nagoya University Graduate School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Harjola VP, Lassus J, Sionis A, et al. Clinical picture and risk prediction of short-term mortality in cardiogenic shock. Eur J Heart Fail 17 (5): 501-509, 2015.","DOI":"10.1002\/ejhf.260"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Geller BJ, Sinha SS, Kapur NK, et al. Escalating and De-escalating Temporary Mechanical Circulatory Support in Cardiogenic Shock: A Scientific Statement From the American Heart Association. Circulation 146 (6): e50-e68, 2022.","DOI":"10.1161\/CIR.0000000000001076"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Haurand JM, Haberkorn S, Haschemi J, et al. Outcome of patients with non-ischemic cardiogenic shock supported by percutaneous left ventricular assist device. ESC Heart Fail 8 (5): 3594-3602, 2021.","DOI":"10.1002\/ehf2.13546"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Iannaccone M, Albani S, Giannini F, et al. Short term outcomes of Impella in cardiogenic shock: A review and meta-analysis of observational studies. Int J Cardiol 324: 44-51, 2021.","DOI":"10.1016\/j.ijcard.2020.09.044"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Ouweneel DM, Henriques JP. Percutaneous cardiac support devices for cardiogenic shock: current indications and recommendations. Heart 98 (16): 1246-1254, 2012.","DOI":"10.1136\/heartjnl-2012-301963"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Schafer A, Werner N, Burkhoff D, et al. Influence of Timing and Predicted Risk on Mortality in Impella-Treated Infarct-Related Cardiogenic Shock Patients. Front Cardiovasc Med 7: 74, 2020.","DOI":"10.3389\/fcvm.2020.00074"},{"key":"7","unstructured":"7. Moller JE, Engstrom T, Jensen LO, et al. Microaxial Flow Pump or Standard Care in Infarct-Related Cardiogenic Shock. N Engl J Med 390 (15): 1382-1393, 2024."},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Saito Y, Tateishi K, Toda K, Matsumiya G, Kobayashi Y, investigators JPrs. Complications and Outcomes of Impella Treatment in Cardiogenic Shock Patients With and Without Acute Myocardial Infarction. J Am Heart Assoc 12 (17): e030819, 2023.","DOI":"10.1161\/JAHA.123.030819"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Seyfarth M, Sibbing D, Bauer I, et al. A randomized clinical trial to evaluate the safety and efficacy of a percutaneous left ventricular assist device versus intra-aortic balloon pumping for treatment of cardiogenic shock caused by myocardial infarction. J Am Coll Cardiol 52 (19): 1584-1588, 2008.","DOI":"10.1016\/j.jacc.2008.05.065"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Sugimura Y, Katahira S, Immohr MB, et al. Initial experience covering 50 consecutive cases of large Impella implantation at a single heart centre. ESC Heart Fail 8 (6): 5168-5177, 2021.","DOI":"10.1002\/ehf2.13594"},{"key":"11","unstructured":"11. Schrage B, Sundermeyer J, Beer BN, et al. Use of mechanical circulatory support in patients with non-ischaemic cardiogenic shock. Eur J Heart Fail 25 (4): 562-572, 2023."},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Smith M, Vukomanovic A, Brodie D, Thiagarajan R, Rycus P, Buscher H. Duration of veno-arterial extracorporeal life support (VA ECMO) and outcome: an analysis of the Extracorporeal Life Support Organization (ELSO) registry. Crit Care 21 (1): 45, 2017.","DOI":"10.1186\/s13054-017-1633-1"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Krishnamoorthy A, DeVore AD, Sun JL, et al. Impact of failing right heart in patients supported by intra-aortic balloon counterpulsation. Eur Heart J Acute Cardiovasc Care 6 (8): 709-718, 2017.","DOI":"10.1177\/2048872616652262"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Kapur NK, Kanwar M, Sinha SS, et al. Criteria for Defining Stages of Cardiogenic Shock Severity. J Am Coll Cardiol 80 (3): 185-198, 2022.","DOI":"10.1016\/j.jacc.2022.04.049"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Caforio AL, Pankuweit S, Arbustini E, et al. Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J 34 (33): 2636-2648, 48a-48d, 2013.","DOI":"10.1093\/eurheartj\/eht210"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Ortuno S, Delmas C, Diehl JL, et al. Weaning from veno-arterial extra-corporeal membrane oxygenation: which strategy to use? Ann Cardiothorac Surg 8 (1): E1-E8, 2019.","DOI":"10.21037\/acs.2018.08.05"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Tschope C, Spillmann F, Potapov E, et al. The "TIDE"-Algorithm for the Weaning of Patients With Cardiogenic Shock and Temporarily Mechanical Left Ventricular Support With Impella Devices. A Cardiovascular Physiology-Based Approach. Front Cardiovasc Med 8: 563484, 2021.","DOI":"10.3389\/fcvm.2021.563484"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Sandrio S, Krebs J, Leonardy E, Thiel M, Schoettler JJ. Vasoactive Inotropic Score as a Prognostic Factor during (Cardio-) Respiratory ECMO. J Clin Med 11 (9): 2022.","DOI":"10.3390\/jcm11092390"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Lorusso R, Centofanti P, Gelsomino S, et al. Venoarterial Extracorporeal Membrane Oxygenation for Acute Fulminant Myocarditis in Adult Patients: A 5-Year Multi-Institutional Experience. Ann Thorac Surg 101 (3): 919-926, 2016.","DOI":"10.1016\/j.athoracsur.2015.08.014"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Matassini MV, Marini M, Angelozzi A, et al. Clinical outcomes and predictors of success with Impella weaning in cardiogenic shock: a single-center experience. Front Cardiovasc Med 10: 1171956, 2023.","DOI":"10.3389\/fcvm.2023.1171956"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Nakamura M, Imamura T, Nakagaito M, Ueno H, Kinugawa K, investigators JP. Association Between Impella Device Type and Short-Term Prognosis in Patients with Acute Myocardial Infarction-Related Cardiogenic Shock Receiving ECPELLA Support. Int Heart J 65 (6): 1049-1057, 2024.","DOI":"10.1536\/ihj.24-385"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Maniuc O, Salinger T, Anders F, et al. Impella CP use in patients with non-ischaemic cardiogenic shock. ESC Heart Fail 6 (4): 863-866, 2019.","DOI":"10.1002\/ehf2.12446"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Patsalis N, Kreutz J, Chatzis G, et al. Early risk predictors of acute kidney injury and short-term survival during Impella support in cardiogenic shock. Sci Rep 14 (1): 17484, 2024.","DOI":"10.1038\/s41598-024-68376-w"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Ouweneel DM, Eriksen E, Sjauw KD, et al. Percutaneous Mechanical Circulatory Support Versus Intra-Aortic Balloon Pump in Cardiogenic Shock After Acute Myocardial Infarction. J Am Coll Cardiol 69 (3): 278-287, 2017.","DOI":"10.1016\/j.jacc.2016.10.022"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Dixon SR, Henriques JP, Mauri L, et al. A prospective feasibility trial investigating the use of the Impella 2.5 system in patients undergoing high-risk percutaneous coronary intervention (The PROTECT I Trial): initial U.S. experience. JACC Cardiovasc Interv 2 (2): 91-96, 2009.","DOI":"10.1016\/j.jcin.2008.11.005"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Abdullah KQA, Roedler JV, Vom Dahl J, et al. Impella use in real-world cardiogenic shock patients: Sobering outcomes. PLoS One 16 (2): e0247667, 2021.","DOI":"10.1371\/journal.pone.0247667"},{"key":"27","doi-asserted-by":"publisher","unstructured":"27. Panoulas V, Monteagudo-Vela M. Predictors of Short-term Survival in Cardiogenic Shock Patients Requiring Left Ventricular Support Using the Impella CP or 5.0. CJC Open 3 (8): 1002-1009, 2021.","DOI":"10.1016\/j.cjco.2021.03.008"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Nasu T, Ninomiya R, Koeda Y, Morino Y. Impella device in fulminant myocarditis: Japanese Registry for Percutaneous Ventricular Assist Device (J-PVAD) registry analysis on outcomes and adverse events. Eur Heart J Acute Cardiovasc Care 13 (3): 275-283, 2024.","DOI":"10.1093\/ehjacc\/zuad149"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Rohm CL, Gadidov B, Leitson M, Ray HE, Prasad R. Predictors of Mortality and Outcomes of Acute Severe Cardiogenic Shock Treated with the Impella Device. Am J Cardiol 124 (4): 499-504, 2019.","DOI":"10.1016\/j.amjcard.2019.05.039"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Pieri M, Ortalda A, Altizio S, et al. Prolonged Impella 5.0\/5.5 support within different pathways of care for cardiogenic shock: the experience of a referral center. Front Cardiovasc Med 11: 1379199, 2024.","DOI":"10.3389\/fcvm.2024.1379199"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Gill G, Rowe G, Chen Q, et al. Bridging with surgically placed microaxial left ventricular assist devices: a high-volume centre experience. Eur J Cardiothorac Surg 63 (6): 2023.","DOI":"10.1093\/ejcts\/ezad116"},{"key":"32","doi-asserted-by":"publisher","unstructured":"32. Schrage B, Becher PM, Bernhardt A, et al. Left Ventricular Unloading Is Associated With Lower Mortality in Patients With Cardiogenic Shock Treated With Venoarterial Extracorporeal Membrane Oxygenation: Results From an International, Multicenter Cohort Study. Circulation 142 (22): 2095-2106, 2020.","DOI":"10.1161\/CIRCULATIONAHA.120.048792"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Schrage B, Weimann J, Dabboura S, et al. Patient Characteristics, Treatment and Outcome in Non-Ischemic vs. Ischemic Cardiogenic Shock. J Clin Med 9 (4): 2020.","DOI":"10.3390\/jcm9040931"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Sieweke JT, Akin M, Stetskamp S, et al. Mechanical circulatory support in refractory cardiogenic shock due to influenza virus-related myocarditis. Eur Respir J 56 (3): 2020.","DOI":"10.1183\/13993003.00925-2020"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Shah M, Patel B, Tripathi B, et al. Hospital mortality and thirty day readmission among patients with non-acute myocardial infarction related cardiogenic shock. Int J Cardiol 270: 60-67, 2018.","DOI":"10.1016\/j.ijcard.2018.06.036"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Bertoldi LF, Montisci A, Delmas C, Pappalardo F. Weaning from Impella and mobilization of Impella patients. Eur Heart J Suppl 23 (Suppl A): A41-A45, 2021.","DOI":"10.1093\/eurheartj\/suab008"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Suzuki S, Teraoka N, Ito K, et al. A Novel Predictive Score Model for Successful Weaning From Mechanical Circulatory Support in Patients With Cardiogenic Shock. J Card Fail 31 (5): 791-799, 2025.","DOI":"10.1016\/j.cardfail.2024.07.023"},{"issue":"2","key":"38","doi-asserted-by":"crossref","first-page":"e135","DOI":"10.4244\/EIJ-D-23-00512","volume":"20","author":"S Min","year":"2024","unstructured":"38. Min S, Basir MB, Lemor A, et al. Clinical characteristics and outcomes of patients requiring prolonged mechanical circulatory support after high-risk percutaneous coronary intervention. EuroIntervention 20 (2): e135-e145, 2024.","journal-title":"EuroIntervention","ISSN":"https:\/\/id.crossref.org\/issn\/1774-024X","issn-type":"print"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39. Cohen WG, Rekhtman D, Iyengar A, et al. Extended Support With the Impella 5.5: Transplant, ECMO, and Complications. Asaio j 69 (7): 642-648, 2023.","DOI":"10.1097\/MAT.0000000000001931"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40. Randhawa VK, Al-Fares A, Tong MZY, et al. A Pragmatic Approach to Weaning Temporary Mechanical Circulatory Support: A State-of-the-Art Review. JACC Heart Fail 9 (9): 664-673, 2021.","DOI":"10.1016\/j.jchf.2021.05.011"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41. Papolos AI, Barnett CF, Tuli A, Vavilin I, Kenigsberg BB. Impella Management for the Cardiac Intensivist. ASAIO J 68 (6): 753-758, 2022.","DOI":"10.1097\/MAT.0000000000001680"},{"key":"42","doi-asserted-by":"publisher","unstructured":"42. Kanaoka K, Onoue K, Terasaki S, et al. Features and Outcomes of Histologically Proven Myocarditis With Fulminant Presentation. Circulation 146 (19): 1425-1433, 2022.","DOI":"10.1161\/CIRCULATIONAHA.121.058869"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43. Torres MAR, Texeira TF, Camarozano AC, et al. The value of a simplified approach to end-systolic volume measurement for assessment of left ventricular contractile reserve during stress-echocardiography. Int J Cardiovasc Imaging 35 (6): 1019-1026, 2019.","DOI":"10.1007\/s10554-019-01599-5"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/advpub\/0\/advpub_7329-26\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T03:26:00Z","timestamp":1784949960000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/advpub\/0\/advpub_7329-26\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":43,"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.7329-26","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"article-number":"7329-26"}}